Jounce Therapeutics Price on March 28, 2023

JNCEDelisted Stock  USD 1.88  0.00  0.00%   
If you're considering investing in Jounce Stock, it is important to understand the factors that can impact its price. As of today, the current price of Jounce Therapeutics stands at 1.88, as last reported on the 26th of November, with the highest price reaching 1.88 and the lowest price hitting 1.88 during the day. We have found twenty-four technical indicators for Jounce Therapeutics, which you can use to evaluate the volatility of the firm. Please check out Jounce Therapeutics' Market Risk Adjusted Performance of 0.9892, risk adjusted performance of 0.111, and Downside Deviation of 4.21 to validate if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Jounce Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
JNCE
Based on monthly moving average Jounce Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Jounce Therapeutics by adding Jounce Therapeutics to a well-diversified portfolio.

Jounce Therapeutics Main Headline on 28th of March 2023

Jounce Therapeutics is set to be acquired by Concentra Biosciences, spurning an all-share merger deal with British biotech firm Redx Pharma.

Jounce Therapeutics Valuation on March 28, 2023

It is possible to determine the worth of Jounce Therapeutics on a given historical date. On March 28, 2023 Jounce was worth 1.83 at the beginning of the trading date compared to the closed value of 1.84. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Jounce Therapeutics stock. Still, in general, we apply an absolute valuation method to find Jounce Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Jounce Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Jounce Therapeutics' related companies.
 Open High Low Close Volume
  1.87    1.90    1.81    1.83    15,863,597  
03/28/2023
  1.83    1.85    1.83    1.84    11,195,105  
  1.84    1.86    1.84    1.85    3,350,982  
Backtest Jounce Therapeutics  |  Jounce Therapeutics History  |  Jounce Therapeutics Valuation   PreviousNext  
Open Value
1.83
1.84
Closing Value
1.83
Upside

Jounce Therapeutics Trading Date Momentum on March 28, 2023

On March 29 2023 Jounce Therapeutics was traded for  1.85  at the closing time. The top price for the day was 1.86  and the lowest listed price was  1.84 . The trading volume for the day was 3.4 M. The trading history from March 29, 2023 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 0.54% . The trading delta at closing time against the current closing price is 1.63% .

Jounce Therapeutics Fundamentals Correlations and Trends

By evaluating Jounce Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Jounce Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Jounce financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Jounce Therapeutics Stock history

Jounce Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Jounce is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Jounce Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Jounce Therapeutics stock prices may prove useful in developing a viable investing in Jounce Therapeutics
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. Jounce Therapeutics, Inc. was incorporated in 2012 and is headquartered in Cambridge, Massachusetts. Jounce Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 137 people.

Jounce Therapeutics Stock Technical Analysis

Jounce Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Jounce Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Jounce Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Jounce Therapeutics Period Price Range

Low
November 26, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Jounce Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Jounce Therapeutics November 26, 2024 Market Strength

Market strength indicators help investors to evaluate how Jounce Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Jounce Therapeutics shares will generate the highest return on investment. By undertsting and applying Jounce Therapeutics stock market strength indicators, traders can identify Jounce Therapeutics entry and exit signals to maximize returns

Jounce Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Jounce Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Jounce Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Jounce to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Consideration for investing in Jounce Stock

If you are still planning to invest in Jounce Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Jounce Therapeutics' history and understand the potential risks before investing.
Stocks Directory
Find actively traded stocks across global markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years